We report a case of a patient who developed a severe case of follicular conjunctivitis from brinzolamide after 1.5 years of consistent use. This patient was rechallenged again after resolution of the follicles and subsequently redeveloped similar conjunctivitis. This is the first confirmed reported case of follicular conjunctivitis from brinzolamide use.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218271PMC
http://dx.doi.org/10.1097/IJG.0000000000001063DOI Listing

Publication Analysis

Top Keywords

follicular conjunctivitis
12
case follicular
8
conjunctivitis brinzolamide
8
brinzolamide-induced follicular
4
conjunctivitis
4
conjunctivitis report
4
report case
4
case patient
4
patient developed
4
developed severe
4

Similar Publications

Background: Following interventions to eliminate trachoma in the Afar region of Ethiopia, our goal was to reassess the prevalence of trachomatous trichiasis (TT) and trachomatous inflammation-follicular (TF) at the woreda level, and to identify factors associated with the disease.

Methods: Cross-sectional community-based surveys were conducted in 26 trachoma-endemic woredas, employing a standardized approach. Households were selected as the secondary sampling unit.

View Article and Find Full Text PDF

Purpose: Baseline surveys were conducted in Tigray region, Ethiopia, in 2013. Since then, rounds of azithromycin mass drug administration (MDA) have been delivered in-line with international guidance. The purpose of these surveys was to assess trachomatous inflammation-follicular (TF) prevalence following those treatments to enable the region to plan the next steps towards elimination of trachoma.

View Article and Find Full Text PDF

Background: Blepharoconjunctivitis poses a diagnostic challenge due to its diverse etiology, including viral infections. Blepharoconjunctivits can be acute or chronic, self-limiting, or needing medical therapy.

Aim: To review possible viral agents crucial for accurate differential diagnosis in cases of blepharoconjunctivitis.

View Article and Find Full Text PDF

Background: Trachoma programs use the indicator trachomatous inflammation--follicular (TF) to monitor indication for and response to treatment for trachoma at the district level. Alternative indicators, including serologic markers, are increasingly being evaluated for trachoma surveillance. We evaluated seroprevalence of IgG antibodies to the Pgp3 antigen in two districts in Maradi, Niger thought to have low TF prevalence.

View Article and Find Full Text PDF
Article Synopsis
  • Mozambique is progressing in eliminating trachoma, but some districts still have TF prevalence above the 5% threshold despite interventions like antibiotic distribution.
  • A study in August 2022 tested residents in four districts for trachoma and other factors like water and hygiene, focusing on children aged 1-9 years.
  • Findings showed TF prevalence between 1.1% and 6.0%, with lower prevalence in three districts, while seroprevalence and transmission rates varied, providing valuable data for monitoring trachoma programs.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!